sacituzumab
gilead sciences
['breast', 'sacituzumab', 'tropics02']
esmo 22 . highlights . sacituzumab govitecan showing significant os benifit of 3.2 months in heavily pre treated hr positive her2 negative advanced breast cancer. tropics02 . 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists